| |
|

| CLOZAM® (CLOBAZAM) |
| :: Anticonvulsant, Antianxiety :: |
|
Tab. 10 mg |
|
|
|
|
|
|
|
Pharmacologic category
Benzodiazepine ; Anticonvulsant , Antianxiety
Mechanism of action
In general , benzodiazepines act as depressants of the CNS , producing all levels of CNS depression from mild sedation to hypnosis to coma , depending on dose . It is believed that benzodiazepines enhance or facilitate the action of gamma – aminobutyric acid (GABA), the major inhibitory neurotransmitter in the CNS, by causing it to bind more tightly to the GABA type A receptor . By stimulation of GABA receptor in the ascending reticular activating system , benzodiazepines increase inhibition and block both cortical and limbic arousal following stimulation of the brain stem reticular formation . Clobazam reduces the ability of the neuron to depolarize to the threshold required to produce an action potential . Thus , the seizure threshold is raised
Indications
Epilepsy – Clobazam may be used as an adjunct in the treatment of epilepsy in association with other antiepileptics. Clobazam is active against partial and generalized seizures in epilepsy of widely differing etiology in patients of all ages but is usually only indicated for adjunctive therapy . Intermittent therapy with clobazam has been used successfully in women with catamenial epilepsy (seizures associated with menstruation). Short – term therapy may also be useful for patients whose epileptic attacks occur in clusters or as cover for special events.
Anxiety – Clobazam is used in the short – term treatment of acute anxiety.
Phantom limb pain – There has been a mention of the complete relief of phantom limb pain refractory to other therapy.
Side/Adverse effects
Drowsiness ; Ataxia ; Dizziness ; Behavior disorder ; Confusion ; Mental depression; Lethargy ; Slurred speech ; Tremor ; Anterograde amnesia ; Paradoxical reactions including excitation , agitation , hallucinations , and psychosis ; Rash ; Pruritus; Urticaria ; Weight gain ; Xerostomia; Constipation ; Nausea ; Decreased WBCs and other hematologic abnormalities ; Muscle spasm ; Blurred vision
Contraindications
Hypersensitivity to clobazam or any component of the formulation (cross- sensitivity with other benzodiazepines may also exist) ; Narrow – angle glaucoma ; Pregnancy
Warnings / Precautions
Risk – benefit should be considered when the following medical problems exist: Acute alcohol intoxication with depressed vital signs ; History of drug abuse or dependence ; Hepatic function impairment ; Hyperkinesis ; Hypoalbuminemia ; Severe mental depression ; Myasthenia gravis ; Organic brain disorders ; Psychoses ; Severe chronic obstructive pulmonary disease ; Renal function impairment ; Established or suspected sleep apnea; Swallowing abnormality in children . Patients must be cautioned about performing tasks which require mental alertness (eg , operating machinery or driving) . Benzodizepines have been associated with falls and traumatic injury and should be used with extreme caution in patients who are at risk of these events (especially the elderly).
Pregnancy
FDA pregnancy category D. Clobazam crosses the placenta and has been reported to increase the risk of congenital malformations when used during the first trimester of pregnancy . Therefore clobazam should be avoided during pregnancy , especially during the first trimester
Breast–Feeding
Clobazam is distributed into breast milk . Since neonates metabolize benzodiazepine more slowly than adults and accumulation of the benzodiazepines and/or its metabolite may occur , use by nursing mothers may cause sedation, feeding difficulties , and/or weight loss in the infant . Therefore , clobazam is not recommended during breast – feeding period.
Drug Interactions
Prolonged concurrent use with addictive medications , especially CNS depressants with habituating potential may increase the risk of habituation ; caution is recommended . Use of alcohol during treatment with a benzodiazepine is not recommended because potentiation of CNS depressant effects and increasing of the risk of apnea . Caution is recommended when another CNS depression- producing medication is used with a benzodiazepine , and dosage of one or both agents should be reduced . When a benzodiazepine is used with an opioid analgesic , the dosage of the opioid analgesic should be reduced by at least one third and administered in small increments . Carbamazepine concentrations may be increased during concurrent use with a benzodiazepine ; monitoring of carbamazepine blood concentrations as a guide to dosage is recommended. Concurrent use of cimetidine, oral estrogen- containing contraceptive , diltiazem , disulfiram , erythromycin , fluoxetine , fluvoxamine , grapefruit juice, itraconazole , ketoconazole , nefazodone , propoxyphene , ranitidine and verapamil may inhibit the hepatic metabolism of benzodiazepines , resulting in increased plasma concentrations . Collapse , sometimes accompanied by respiratory depression or arrest , has been reported in a few patients receiving clozapine concurrently with benzodiazepine . Concurrent use with benzodiazepines may decrease the therapeutic effects of levodopa . Concurrent use with benzodiazepines may decrease the clearance of zidovudine ; the toxicity of zidovudine potentially could be increased . Reports of clobazam increasing levels of carbamazepine , phenytoin , valproate and phenobarbital exist. Delavirdine , gemfibrozil , isoniazid , omeprazole, ticlopidine , ciprofloxacin , clarithromycin , diclofenac , doxycycline , protease inhibitors , quinidine and verapamil may increase the levels /effects of clobazam . Aminoglutethimide , carbamazepine , nafcillin , phenobarbital , phenytoin and rifamycins may decrease the levels/effects of clobazam . Theophylline may partially antagonize some of the effects of benzodiazepines.
Monitoring Parameters
Respiratory and cardiovascular status.
Dietary Considerations
Clobazam may be taken with or without food.
Administration and dosage
- Usual adult dose: Anticonvulsant – Oral , initially 5 to 15 mg per day . Dosage may be increased gradually as needed.
- Usual adult prescribing limits: 80 mg per day.
- Usual pediatric dose: Anticonvulsant– Children younger than 2 years of age : Oral , initially 0.5 to 1 mg per kg of body weight per day.
- Children 2 to 16 years of age: Oral , initially 5 mg per day.
Dosage may be increased at five – day intervals.
- Usual pediatric prescribing limits: Children 2 to 16 years of age 40 mg per day.
How Supplied
Storage
Store below 30°C. Protect from light and moisture.
References
- USP DI, 2004
- Up To Date, Vol. 13.1 (2005)
- Martindale, The Complete Drug Reference, 33 rd edition 2002
|